Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

897 studies match

clinicaltrialsPublishedShowing 351–400 of 897 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03974022	Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1)	active not recruiting	Phase 1 / Phase 2	315	Dizal PharmaceuticalsINDUSTRY	13	Jan 29, 2026	clinicaltrials
NCT03740529	A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL	completed	Phase 1 / Phase 2	803	Loxo Oncology, Inc.INDUSTRY	10	Jan 27, 2026	clinicaltrials